Sept 24 (Reuters) – Drug developer City Therapeutics filed for a US initial public offering on Thursday, joining a rush of biotech firms lining up to tap the fall IPO window. Biotech has been one of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Even if the sun is shining when Washington welcomes the Seattle Seahawks in their home…
VIDEO SHOWS: ARGENTINA NATIONAL TEAM TRAINING IN EZEIZA AHEAD OF FRIENDLY MATCHES / SOUNDBITES FROM…
The New England Patriots were the best road team in the NFL last season, a…
By David Shepardson WASHINGTON, Sept 24 (Reuters) - The head of industry group Airlines for…
By Harshita Mary Varghese Sept 24 (Reuters) - Anthropic has committed to spending $11.6 billion…
Sept 25 (Reuters) - METRO INC.: * METRO - ANNOUNCES RATIFICATION OF NEW COLLECTIVE AGREEMENT…